Clinical Trial Update: Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of fasudil for early Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• fasudil (fasudil)

Snippet

Sponsor: Helse Stavanger HF | Conditions: Cognitive Decline, Mild, Alzheimer Disease | Phase 2 | Status: RECRUITING